• Search
      • Search Interactions Search Categories
    • Browse
      • Browse Categories Browse Sources
    • Information
      • About Publications Interaction Types & Directionalities Interaction Score & Query Score API Documentation FAQ Known Data Clients News Contact
    • Downloads
      • Data Source Code

TROLEANDOMYCIN Drug Record

  • Summary
  • Interactions
  • Claims
  • TROLEANDOMYCIN chembl:CHEMBL564085 Approved

    Alternate Names:

    ACETYLOLEANDOMYCIN
    TAO
    TROLEANDOMYCIN
    TRIACETYLOLEANDOMYCIN
    NSC-108166
    OLEANDOMYCIN TRIACETYL ESTER
    OLEANDOMYCIN TRIACETATE
    OLEANDOCETINE
    TRIBIOCILLINA
    rxcui:10864
    drugbank:01361
    chembl:CHEMBL564085
    chemidplus:2751-09-9
    pubchem.compound:202225

    Drug Info:

    (0 More Sources)

    Publications:

    Sakatis MZ et al., 2012, Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds., Chem Res Toxicol
    Kobayashi K et al., 2004, Key structural features of ligands for activation of human pregnane X receptor., Drug Metab Dispos
  • TROLEANDOMYCIN   NR1I2

    Interaction Score: 0.28

    Interaction Types & Directionality:
    activator (activating)

    Interaction Info:

    PMIDs:
    15039302


    Sources:
    PharmGKB

  • TROLEANDOMYCIN   CYP2C9

    Interaction Score: 0.07

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    22931300


    Sources:
    DTC

  • TROLEANDOMYCIN   CYP1A2

    Interaction Score: 0.05

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    22931300


    Sources:
    DTC

  • TROLEANDOMYCIN   CYP2D6

    Interaction Score: 0.05

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    22931300


    Sources:
    DTC

  • DTC: TROLEANDOMYCIN

    • Version: 02-September-2020

    Alternate Names:
    CHEMBL564085 ChEMBL Drug ID

    Drug Info:

    Publications:
    Sakatis MZ et al., 2012, Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds., Chem Res Toxicol

  • TTD: Troleandomycin

    • Version: 2020.06.01

    Alternate Names:
    D06IGU TTD Drug ID

    Drug Info:

    Publications:

  • PharmGKB: troleandomycin

    • Version: 18-August-2020

    Alternate Names:

    Drug Info:

    Publications:

  • ChemblDrugs: chembl:CHEMBL564085

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications:

Disclaimer: This resource is intended for purely research purposes. It should not be used for emergencies or medical or professional advice.

A finding of a drug-gene interaction or potentially druggable category does not necessarily indicate effectiveness (or lack thereof) of any drug or treatment regimen. A finding of no interaction or no potentially druggable category does not necessarily indicate lack of effectiveness of any drug or treatment regimen. Drug-gene interactions or potentially druggable categories are not presented in ranked order of potential or predicted efficacy.

The dgidb.org website does not provide any medical or healthcare products, services or advice, and is not for medical emergencies or urgent situations. IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY, CALL YOUR DOCTOR OR 911 IMMEDIATELY. Information contained on this website is not a substitute for a doctor's medical judgment or advice. We recommend that you discuss your specific, individual health concerns with your doctor or health care professional.

DGIdb (v4.2.0 - sha1 afd9f30b) • Last updated 2020-10-21